ClinConnect ClinConnect Logo
Search / Trial NCT06402500

Color Masking Potential of Bioactive and ICON Materials

Launched by KING ABDULLAH UNIVERSITY HOSPITAL · May 3, 2024

Trial Information

Current as of November 05, 2025

Recruiting

Keywords

Resin Infiltration Incipient Lesion Bioactive Material Icon Infiltration Resin

ClinConnect Summary

This clinical trial is studying different materials used to treat white spot lesions (WSLs) on teeth that can appear after wearing braces. WSLs are areas where the enamel has lost minerals, but they haven’t developed into cavities yet. The trial is comparing two treatments: ICON resin infiltration, which is considered the gold standard for this kind of issue, and a bioactive glass adhesive known as HI-Bond. Researchers want to find out if both treatments can effectively mask the color of these white spots and whether they help to add minerals back into the affected teeth.

To participate in this study, patients should be between the ages of 4 and 17 and have specific types of WSLs on their front or side teeth, without any previous dental work on those teeth. However, certain individuals are excluded, such as those with cavities, developmental defects in their teeth, or specific health conditions like diabetes. Participants can expect to receive either of the two treatments and contribute to important research that could help improve dental care for others with similar issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Patients with teeth and WSL fullfiling the following criteria will be included in the study:
  • 1. Anterior and premolar maxillary and mandibular teeth.
  • 2. Teeth with no previous restorations.
  • 3. post-orthodontic white spot lesions WSL with no adjacent restorations in the same tooth.
  • 4. WSL on Labial surfaces of maxillary or mandibular anterior and premolars teeth.
  • Exclusion Criteria: The following will be excluded from the study,
  • 1. Cavitated enamel surface that requires direct composite restorations.
  • 2. Presence of developmental enamel defects on the proposed teeth.
  • 3. Diabetic patients and patients with metabolic syndrome.
  • 4. Pregnant ladies.
  • 5. Smoker patients.

About King Abdullah University Hospital

King Abdullah University Hospital (KAUH) is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Located in Jordan, KAUH is committed to enhancing medical knowledge and improving treatment outcomes by conducting rigorous clinical trials across various therapeutic areas. The hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals, ensuring the highest standards of research integrity and participant safety. Through its collaborative approach and focus on evidence-based medicine, KAUH aims to contribute significantly to the global medical community and the well-being of patients.

Locations

Irbid, None Selected, Jordan

Patients applied

0 patients applied

Trial Officials

Zakereyya SM Albashaireh, PhD

Principal Investigator

Jordan University of Science and Technology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported